NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves

August 18, 2015 By Brad Perriello Leave a Comment

NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it gears up to raise a Series A round for its neuromodulation technology.

NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices. NeuSpera said it’s raised more than $1 million in angel funding so far.

“We are delighted to welcome Milton as NeuSpera’s president & CEO,” NeuSpera chairman Bing Yeh said in prepared remarks. “Bringing with him over 23 years of rich experience in the medical device industry, Milton is a dynamic leader and a talented executive with a proven track record of driving technology innovation and business growth. For the past several months, Milton has been working with the company as a consultant. Under his guidance, the team has made great progress and is now ready to take the next step in addressing the milestones targeted for Series A financing. I am confident that Milton has the leadership qualities and industry experience to propel NeuSpera forward.”

“I am excited to be leading NeuSpera Medical – a young, fast-moving company with a truly innovative technology,” added Morris, who was already a member of the company’s board. “It is a privilege to be in a position to positively impact human lives through medical technology – a privilege that I take seriously. NeuSpera has the opportunity to fundamentally change the way neuromodulation therapy is delivered. I look forward to realizing its great potential.”

NuVasive taps Thermo Fisher’s Lai for IT chief
NuVasive Inc. (NSDQ:NUVA)
said it lured Thermo Fisher‘s (NYSE:TMO) vice president of IT, Johnson Lai, to be its new chief information officer.
Read more

Check-Cap promotes Densel to CEO
Check-Cap (NSDQ:CHEK) said it named Bill Densel to replace Guy Neev as CEO. Densel was the company’s U.S. operations president. Neev is slated to stay on as a consultant through the end of 2015.
Read more

Bone Biologics grabs La Neve for CEO, Frelick for COO
Bone Biologics said it named medtech veteran Stephen La Neve to be its new CEO, replacing interim chief Michael Schuler, and tapped Jeffrey Frelick to be its COO.
Read more

Nephros names former Outset Medical CEO Pinto to board
Nephros (OTC:NEPH) said it named Moshe Pinto, the former CEO of Home Dialysis Plus (now Outset Medical) to its board of directors.
Read more

Sterigenics sues Ga. county to keep EtO plant open after emergency
Sterigenics has sued the government of a Georgia county to force a permanent reopening of the company’s Atlanta medtech sterilization plant. Officials of Cobb County, Ga. recently gave Sterigenics permission to reopen the plant for 21 days to sterilize personal protective equipment for healthcare workers treating COVID-19 patients. Sterigenics had told county officials it has… […]
Medline to reprocess N95 respirators to fight COVID-19 spread
Medline Industries has agreed to reprocess 100,000 N95 respirators and other face masks per day in its facilities beginning as early as this week. The process that Medline plans to use is close to receiving FDA emergency use approval (EUA) and will supplement the more than 38 million masks the company has distributed on average… […]
How FDA is changing medtech regulation under the coronavirus
The FDA’s Center for Devices & Radiological Health (CDRH) has issued a letter to the medtech industry that outlined the steps it is taking to address the impact of the COVID-19 pandemic. The administration has already expressed its openness to issuing emergency use authorization (EUA) for ventilator devices amid a shortage in the U.S. Last… […]
More dangerous than the virus? Converting manual resuscitators to ventilators
The shortage of respiratory ventilators in the face of the COVID-19 pandemic has led to numerous efforts aimed at turning hand-operated plastic pouches called bag-valve resuscitators into makeshift ventilators. The resuscitators, also called Ambu bags, are generally on-hand in large quantities. They are designed to be operated by hand, by trained technicians, to inflate patient… […]
Could respirator decontamination solve shortage problems?
The FDA has issued an emergency use authorization for the Battelle Critical Care Decontamination System, which can decontaminate tens of thousands of respirator masks per day so that health personnel can reuse them. The Columbus, Ohio-based nonprofit tech development company announced on March 28 that it began rapid manufacturing of its system to decontaminate N95 respirator masks and other… […]
Medline reopens Illinois medtech sterilization plant
Medline Industries resumed sterilization operations at its Waukegan, Ill., plant on Friday, following state certification of the company’s $10 million in emission-control upgrades, the company announced. The Waukegan plant reopening follows the decision this week by officials in Cobb County, Ga., to allow an Atlanta Sterigenics EtO plant to reopen for 21 days to sterilize… […]
DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news
In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than… […]
AdvaMed: Invoking Defense Production Act could hinder U.S. medtech imports
Forcing manufacturers to repurpose their production lines to make equipment to fight the coronavirus epidemic might actually hurt the U.S. supply of those items, the head of medtech trade group AdvaMed said today. AdvaMed officials have talked with U.S. secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn about medtech… […]
March 2020 Issue: Is software key to medical 3D printing innovation?
What’s the word on ethylene oxide? The coronavirus pandemic has pushed a lot of news out of people’s minds, but medtech has other big issues to deal with. For instance, 8 months have passed since the FDA issued a public challenge for alternatives to ethylene oxide (EtO) as a sterilant for medical devices. As I… […]
GE Healthcare quadruples ventilator production at Wisconsin plant
General Electric Healthcare (NYSE:GE) this week announced that it is doubling its production capacity for ventilators and expanding its Madison, Wisconsin, production line to 24-hour operation. In a report on GE’s website, the company shared that it has doubled its capacity of ventilator production with plans to double it again by the end of the second… […]
FDA issues FAQ on 3D-printed equipment against coronavirus
Intrepid 3D printing companies and individuals who want to print masks, gowns and other personal protective equipment (PPE) to fight the coronavirus pandemic might want to take a look at the FDA’s new frequently asked questions page on the topic. While it says it welcomes coronavirus-fighting efforts, the agency said that 3D-printed masks are unlikely… […]